Colorectal Cancer Trial, Recruiting NCT06809660 Sponsor: Poitiers University Hospital Condition: Colorectal Cancer
Back to Colorectal Cancer

Colorectal Cancer Trial, Recruiting

NCT06809660
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have an endoscopy (a camera procedure to look inside your digestive system) either scheduled during your first study visit or planned within the next 18 months.
  • You have read and signed a consent form after being fully informed about the study.
  • You are not under any form of legal guardianship or supervised care arrangement.
  • You have health insurance or social security coverage.

Who may not be able to join:

  • You are currently being treated for a chronic inflammatory bowel disease (such as Crohn's disease or ulcerative colitis).
  • You have an inherited condition that increases your risk of colorectal cancer.
  • You have taken antibiotics, probiotics, or prebiotic supplements in the four weeks before your stool sample is collected.
  • You have received chemotherapy or radiotherapy before surgery as part of cancer treatment.
  • You have previously had surgery to remove part of your bowel or intestine.
  • You are a minor, someone held under a legal or court order, someone living in a care or social institution, or an adult under legal protection.
  • You are pregnant or breastfeeding.
  • During the study, if you take antibiotics, probiotics, or prebiotics before your stool sample is collected, you may be removed from the trial.
  • If your endoscopy does not take place within 18 months of joining the study, you may be removed.
  • If your stool sample is not successfully sent or received, you may be removed from the trial.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 9 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 00335 49 44 42 93

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Poitiers University Hospital
Registry
ClinicalTrials.gov
Start date
21 January 2025
Est. completion
21 January 2031

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Association between faecal microbiota disruption and exposure to endocrine disruptors

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 9 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov